Related Experiment Video
Updated: Oct 21, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Mycoplasma hominis infection of the central nervous system in newborn infants
Abstract:
The incidence of infections of the central nervous system caused by Mycoplasma hominis in newborn infants is not known. However, such infections occur in both full-term and premature infants, either with or without malformations such as myelomeningocele. M. hominis has also been recovered from brain abscesses. Infected infants usually present with signs of meningitis or meningoencephalitis. Hydrocephalus may develop. The cerebrospinal fluid characteristically has a reduced glucose content and an elevated protein concentration. The white blood cell count is high, with a predominance of either mono- or polymorphonuclear leukocytes. Cerebrospinal fluid yields M. hominis but not other bacteria. Some newborn infants with M. hominis infection of the central nervous system die, whereas others survive and become healthy. In spite of adequate antibiotic therapy, some of those infected develop sequelae such as hemiplegia. Therapy with tetracycline or lincomycin can rapidly eradicate the organism from cerebrospinal fluid.
Insights
Central nervous system infections in newborns caused by Mycoplasma hominis can lead to meningitis or meningoencephalitis. While some infants recover, others may experience severe sequelae, though antibiotic therapy can be effective.
Area of Science:
- Neonatal infectious diseases
- Neuroscience
- Microbiology
Background:
- Mycoplasma hominis infections in the central nervous system (CNS) of neonates are not well-characterized.
- These infections occur in both full-term and premature infants, sometimes associated with congenital malformations like myelomeningocele.
- M. hominis has been identified in cases of brain abscesses.
Purpose of the Study:
- To describe the clinical presentation, cerebrospinal fluid (CSF) findings, and outcomes of central nervous system infections caused by Mycoplasma hominis in newborn infants.
- To evaluate the efficacy of antibiotic therapy in treating these infections.
Main Methods:
- Case series or retrospective review of neonatal patients diagnosed with CNS infections.
- Analysis of clinical data, including symptoms, neurological signs, and congenital anomalies.
- Cerebrospinal fluid analysis for Mycoplasma hominis detection, glucose, protein, and cell counts.
- Assessment of treatment regimens and patient outcomes.
Main Results:
- Infected infants typically present with signs of meningitis or meningoencephalitis, with potential development of hydrocephalus.
- Cerebrospinal fluid analysis often reveals reduced glucose, elevated protein, and high white blood cell counts (mononuclear or polymorphonuclear predominance).
- Mycoplasma hominis was isolated from CSF when other bacteria were absent; outcomes varied, with some infants succumbing to infection, others recovering fully, and some developing sequelae like hemiplegia despite treatment.
Conclusions:
- Mycoplasma hominis represents a significant cause of CNS infections in neonates, presenting with diverse clinical manifestations and outcomes.
- Early diagnosis and appropriate antibiotic therapy, such as tetracycline or lincomycin, are crucial for eradicating the organism from CSF and improving patient prognosis.
- Despite effective treatment, long-term neurological sequelae can occur, highlighting the importance of continued monitoring and supportive care.
Related Concept Videos
Bacterial Meningitis
Atypical Pneumonia
Viral Meningitis
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology

